Compare
Precision Optics Corporation, Inc. vs QT Imaging Holdings, Inc. vs Hyperfine, Inc. vs Escalon Medical Corp
| Latest fiscal year | Precision Optics Corporation, Inc. POCI | QT Imaging Holdings, Inc. QTI | Hyperfine, Inc. HYPR | Escalon Medical Corp ESMC |
|---|---|---|---|---|
| Year ended | 2025-06-30 | 2025-12-31 | 2025-12-31 | 2025-06-30 |
| Revenue | $19.09M | $18.93M | $13.56M | $12.05M |
| Revenue growth (YoY) | -0.1% | +287.9% | +5.2% | +0.5% |
| Gross margin | 17.8% | 45.4% | 49.8% | 45.7% (computed) |
| Operating margin | -29.1% | -23.4% | -273.4% | 1.1% |
| Net margin | -30.3% | -111.4% | -262.3% | 0.9% |
| Net income | -$5.78M | -$21.08M | -$35.57M | $105.5K |
| EPS (Diluted) | -$0.85 | -$2.01 | -$0.43 | $0.00 |
| Operating cash flow | -$3.55M | -$8.96M | -$27.95M | $380.7K |
| Free cash flow | -$3.77M | -$9.08M | -$29.13M | $376.8K |
| Cash & equivalents | $1.77M | $10.41M | $35.09M | $545.8K |
| Total assets | $19.79M | $23.02M | $55.26M | $4.99M |
| Total liabilities | $7.53M | $16.58M | $14.26M | $3.08M |
| Shareholders' equity | $12.26M | $6.45M | $41.01M | $1.92M |
| Return on year-end equity | -47.2% | -327.1% | -86.8% | 5.5% |
| Shares outstanding | 7.71M | 11.90M | n/a | 7.42M |
Revenue, most recent five fiscal years
| Fiscal year | Precision Optics Corporation, Inc. | QT Imaging Holdings, Inc. | Hyperfine, Inc. | Escalon Medical Corp |
|---|---|---|---|---|
| Latest | $19.09M Ended 2025-06-30 | $18.93M Ended 2025-12-31 | $13.56M Ended 2025-12-31 | $12.05M Ended 2025-06-30 |
| 1 year earlier | $19.10M Ended 2024-06-30 | $4.88M Ended 2024-12-31 | $12.89M Ended 2024-12-31 | $11.98M Ended 2024-06-30 |
| 2 years earlier | $21.04M Ended 2023-06-30 | $40.4K Ended 2023-12-31 | $11.03M Ended 2023-12-31 | $12.18M Ended 2023-06-30 |
| 3 years earlier | $15.68M Ended 2022-06-30 | n/a | $6.81M Ended 2022-12-31 | $10.70M Ended 2022-06-30 |
| 4 years earlier | $10.67M Ended 2021-06-30 | n/a | $1.50M Ended 2021-12-31 | $10.47M Ended 2021-06-30 |